Search results
Strengthening CAR-T therapy to work against solid tumors
Medical Xpress· 4 hours agoThe promising findings, reported in Science Advances, involve CAR-T cell therapy, which supercharges...
Valley Children’s in Madera County Receives Historic $15 Million Gift to Create Advanced Cell ...
Sierra Sun Times· 5 days ago“This gift will bring transformational cancer therapies directly to the children whose families look...
Does Valley Children’s prioritize patient care or profitability? It’s a fair question | Opinion
Fresno Bee McClatchy via AOL· 5 hours agoEven joyous. Once the programs get established and certified, patients in need of bone marrow...
Identification of clinically relevant T cell receptors for personalized T cell therapy using...
Nature· 2 days agoTumor-reactive T cell receptors are predicted based on single-cell RNA sequencing and single-cell T cell receptor sequencing.
Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem...
Newswise· 2 days ago(YCC) and Smilow Cancer Hospital (SCH) have again received an internationally recognized accreditation for cellular therapy and stem cell transplantation from the Foundation ...
AI predicts tumor-killing cells with high accuracy, study shows
Medical Xpress· 1 day agoCombined with additional algorithms, the predictive model, described in the current issue of the journal Nature Biotechnology, can be applied to personalized cancer treatments that tailor < ...
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 hour agoReshma will talk to our pipeline progress. Commercially, in the United States, we are pleased with...
Newly discovered mechanism of T-cell control can interfere with cancer immunotherapies
Medical Xpress· 5 days agoResearchers from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim...
Vyriad Announces Oral Presentation at the 27th American Society of Gene & Cell Therapy Annual...
KTLA-TV Los Angeles· 2 days agoVyriad's presentation will discuss progress in developing its highly targeted, efficient, serum-stable and durable lentiviral vector technology to deliver genetic...
TC BioPharm to acquire CAR-T therapy developer By Investing.com
Investing.com· 2 days agoTC BioPharm (Holdings) PLC (NASDAQ: TCBP), a clinical-stage biopharmaceutical company, today...